-M Mclean Researcher Activity Profile

Research Author Detailed Information 

M Mclean Publication Rate By Year

M Mclean has published 1 paper(s) in 1949, 16 paper(s) in 2007, for a total of 17 research publications in total.

M M Mclean Author Information

LAST NAME: mclean

FIRST NAME: M

INITIALS: m

AFFILIATION:

Papers

M Mclean's Publication Record

1. In this issue of Current Oncology. Year Published: 2007
2. The nature and extent of urinary morbidity in relation to prostate brachytherapy urethral dosimetry. Year Published: 2007
Department of Urology, Princess Margaret Hospital, 610 University Avenue, Toronto, Ontario, Canada.
3. In this issue of Current Oncology. Year Published: 2007
4. Directly observed therapy for the treatment of hepatitis C virus infection in current and former injection drug users. Year Published: 2007
Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada. jgrebely@interchange.ubc.ca
5. Desirable performance standards for HbA(1c) analysis - precision, accuracy and standardisation: consensus statement of the Australasian Association of Clinical Biochemists (AACB), the Australian Diabetes Society (ADS), the Royal College of Pathologists of Australasia (RCPA), Endocrine Society of Australia (ESA), and the Australian Diabetes Educators Association (ADEA). Year Published: 2007
Biochemistry Department, Division of Laboratory Medicine, Austin Health, Heidelberg, Victoria, Australia. ian.goodall@austin.org.au
6. In this issue of Current Oncology. Year Published: 2007
7. Five year results of a randomized trial comparing hyperfractionated to conventional radiotherapy over four weeks in locally advanced head and neck cancer. Year Published: 2007
Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Ontario, Canada.
8. Poor peak dorsiflexor torque associated with incidence of ankle injury in elite field female hockey players. Year Published: 2007
School of Medical Sciences, University of KwaZulu-Natal, South Africa.
9. Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinoma. Year Published: 2007
Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada.
10. Poor peak dorsiflexor torque associated with incidence of ankle injury in elite field female hockey players. Year Published: 2007
School of Medical Sciences, University of KwaZulu-Natal, South Africa.
11. Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinoma. Year Published: 2007
Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada.
12. Five year results of a randomized trial comparing hyperfractionated to conventional radiotherapy over four weeks in locally advanced head and neck cancer. Year Published: 2007
Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Ontario, Canada.
13. The nature and extent of urinary morbidity in relation to prostate brachytherapy urethral dosimetry. Year Published: 2007
Department of Urology, Princess Margaret Hospital, 610 University Avenue, Toronto, Ontario, Canada.
14. Unusual case of nutritional anaemia. Year Published: 1949
15. Desirable performance standards for HbA(1c) analysis - precision, accuracy and standardisation: consensus statement of the Australasian Association of Clinical Biochemists (AACB), the Australian Diabetes Society (ADS), the Royal College of Pathologists of Australasia (RCPA), Endocrine Society of Australia (ESA), and the Australian Diabetes Educators Association (ADEA). Year Published: 2007
Biochemistry Department, Division of Laboratory Medicine, Austin Health, Heidelberg, Victoria, Australia. ian.goodall@austin.org.au
16. Poor peak dorsiflexor torque associated with incidence of ankle injury in elite field female hockey players. Year Published: 2007
School of Medical Sciences, University of KwaZulu-Natal, South Africa.
17. Five year results of a randomized trial comparing hyperfractionated to conventional radiotherapy over four weeks in locally advanced head and neck cancer. Year Published: 2007
Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Ontario, Canada.